Quick Links


U.S. senator begins investigation into treatment of FDA whistleblowers

After six current or former Food and Drug Administration employees complained that their e-mails were being monitored, Senator Charles E. Grassley (R-Iowa) ordered an investigation into the FDA’s monitoring program aimed at doctors and scientists alarmed that unsafe medical devices were approved.

Grassley said, “I write to express my concerns over your agency’s treatment of whistleblowers as a result of their disclosures to Congress, and specifically disclosures to my office. Whistleblowers . . . are often treated like skunks at a picnic.” -db

From The Washington Post, February 1, 2012, by Lisa Rein and Ellen Nakashima.

Full story



Your contributions make our work possible.

, , ,

Comments are closed.

Powered by WordPress. Designed by WooThemes